These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23586452)

  • 21. Neurocognitive Empowerment for Addiction Treatment (NEAT): study protocol for a randomized controlled trial.
    Ekhtiari H; Rezapour T; Sawyer B; Yeh HW; Kuplicki R; Tarrasch M; Paulus MP; Aupperle R
    Trials; 2021 May; 22(1):330. PubMed ID: 33962675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychological Interventions for Decision-Making in Addiction: a Systematic Review.
    Verdejo-García A; Alcázar-Córcoles MA; Albein-Urios N
    Neuropsychol Rev; 2019 Mar; 29(1):79-92. PubMed ID: 30259388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical Therapy.
    Xiao LJ; Tao R
    Adv Exp Med Biol; 2017; 1010():247-260. PubMed ID: 29098676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scientific and conceptual flaws of coercive treatment models in addiction.
    Uusitalo S; van der Eijk Y
    J Med Ethics; 2016 Jan; 42(1):18-21. PubMed ID: 26463621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive Neuroscience Approaches to Understanding Behavior Change in Alcohol Use Disorder Treatments.
    Naqvi NH; Morgenstern J
    Alcohol Res; 2015; 37(1):29-38. PubMed ID: 26259087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nutrition Support Therapy.
    Xiao LJ; Tao R
    Adv Exp Med Biol; 2017; 1010():281-293. PubMed ID: 29098678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental medicine in drug addiction: towards behavioral, cognitive and neurobiological biomarkers.
    Duka T; Crombag HS; Stephens DN
    J Psychopharmacol; 2011 Sep; 25(9):1235-55. PubMed ID: 21169391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroscience research on the addictions: a prospectus for future ethical and policy analysis.
    Hall W; Carter L; Morley KI
    Addict Behav; 2004 Sep; 29(7):1481-95. PubMed ID: 15345277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy combined with specified ingredients: a new direction for empirically supported addiction treatment.
    Magill M; Longabaugh R
    Addiction; 2013 May; 108(5):874-81. PubMed ID: 23072622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using Neuroscience to Augment Behavioral Interventions for Depression.
    Vinograd M; Craske MG
    Harv Rev Psychiatry; 2020; 28(1):14-25. PubMed ID: 31913979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are "physiological" and "psychological" addiction really different? well, no! ... um, er, yes?
    Newlin DB
    Subst Use Misuse; 2008; 43(7):967-71. PubMed ID: 18570028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definition of Substance and Non-substance Addiction.
    Zou Z; Wang H; d'Oleire Uquillas F; Wang X; Ding J; Chen H
    Adv Exp Med Biol; 2017; 1010():21-41. PubMed ID: 29098666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dual-systems perspective on addiction: contributions from neuroimaging and cognitive training.
    McClure SM; Bickel WK
    Ann N Y Acad Sci; 2014 Oct; 1327():62-78. PubMed ID: 25336389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroscience of behavioral and pharmacological treatments for addictions.
    Potenza MN; Sofuoglu M; Carroll KM; Rounsaville BJ
    Neuron; 2011 Feb; 69(4):695-712. PubMed ID: 21338880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery from addiction: Behavioral economics and value-based decision making.
    Field M; Heather N; Murphy JG; Stafford T; Tucker JA; Witkiewitz K
    Psychol Addict Behav; 2020 Feb; 34(1):182-193. PubMed ID: 31599604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applying incentive sensitization models to behavioral addiction.
    Rømer Thomsen K; Fjorback LO; Møller A; Lou HC
    Neurosci Biobehav Rev; 2014 Sep; 45():343-9. PubMed ID: 25036890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study.
    Yücel M; Oldenhof E; Ahmed SH; Belin D; Billieux J; Bowden-Jones H; Carter A; Chamberlain SR; Clark L; Connor J; Daglish M; Dom G; Dannon P; Duka T; Fernandez-Serrano MJ; Field M; Franken I; Goldstein RZ; Gonzalez R; Goudriaan AE; Grant JE; Gullo MJ; Hester R; Hodgins DC; Le Foll B; Lee RSC; Lingford-Hughes A; Lorenzetti V; Moeller SJ; Munafò MR; Odlaug B; Potenza MN; Segrave R; Sjoerds Z; Solowij N; van den Brink W; van Holst RJ; Voon V; Wiers R; Fontenelle LF; Verdejo-Garcia A
    Addiction; 2019 Jun; 114(6):1095-1109. PubMed ID: 30133930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of technology-assisted self-help and minimal contact therapies for drug and alcohol abuse and smoking addiction: is human contact necessary for therapeutic efficacy?
    Newman MG; Szkodny LE; Llera SJ; Przeworski A
    Clin Psychol Rev; 2011 Feb; 31(1):178-86. PubMed ID: 21095051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transitionality in addiction: A "temporal continuum" hypotheses involving the aberrant motivation, the hedonic dysregulation, and the aberrant learning.
    Patrono E; Gasbarri A; Tomaz C; Nishijo H
    Med Hypotheses; 2016 Aug; 93():62-70. PubMed ID: 27372858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mindfulness-based interventions: an antidote to suffering in the context of substance use, misuse, and addiction.
    Black DS
    Subst Use Misuse; 2014 Apr; 49(5):487-91. PubMed ID: 24611846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.